1.
Iqbal F. Enhancing the effectiveness of Chimeric Antigen Receptor (CAR) T cells against tumors through CRISPR/Cas9-mediated PD-1 disruption. Int. J. of Health Sci. [Internet]. 2023 Jul. 4 [cited 2026 Jun. 7];7(S1):1836-50. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/14397